Introduction: Patients suffering from nasal obstruction due to nasal valve compromise may benefit from a nasal dilator. Several devices for widening of the external/internal nasal valve region can be applied endonasally (Airmax®, Nasanita®, Nozovent®) or externally (Breathe Right®).
Introduction
Symptoms of nasal obstruction have an effect on sleep, exercise, and can interfere with the patient's quality of life. Nasal valve compromise (NVC) has been recognized as an important source of nasal obstruction (1) . In many individuals, valve effects may equal or surpass septal deviation as the primary cause of nasal airflow obstruction (2) and therefore nasal valve function should be assessed in all patients that present with nasal obstruction.
NVC can be due to congenital reasons, trauma, previous surgery, facial nerve palsy, and/or weakness of the nasal cartilages, or intrinsic aging.
The nasal valves have been proposed to be a major regulator of nasal airflow, preventing airflow from exceeding the capacity to warm and humidify inspired air (3) . By means of having the smallest cross-sectional area of the entire respiratory tract, the nasal valves are the primary location of the greatest nasal airflow resistance (4) . As air enters this constricted segment of the airway, acceleration of the airflow occurs. This results in a drop in intraluminal pressure by the Bernoulli principle. The pressure drop can lead to collapse of this segment of the airway during inspiration. Whether or not this force leads to actual symptomatic collapse of the lateral nasal wall, depends on the intrinsic stability and on the pressure changes to which it is subjected during quite and forced inspiration (5) . Abbreviations The surgical philosophies usually fall into the following broad categories: Increasing either the rigidity and/or the diameter of the nasal valve (6) . In principle the existing surgical techniques for treatment of the nasal valve region improve the ability to overcome a negative pressure drop. Whether that is due to increasing the diameter of the region or increasing the rigidity of the wall or both is unclear.
Additionally in those patients where surgery is neither primarily indicated nor desired, non-surgical options should be discussed.
The use of nasal dilators is a relatively new treatment modality for nasal obstruction secondary to NVC.
This study was performed to compare the subjective and objective benefits between four different nasal dilators in adults with NVC, as well as the patients' tolerability and preference for these devices. Testing different nasal dilators regarding their ability to stent the anterior nasal airway and subsequent increase in peak nasal inspiratory flow (PNIF), may aid in gaining knowledge of whether or not there is therapeutic superiority in using one type of device over the others, in order to ameliorate nasal obstruction. 
Materials and methods

Participants
The surgeons conducting the study (PWH & GL) diagnosed nasal valve compromise based on clinical examination that included Cottle or modified Cottle maneuver (7) , dynamic lateral wall or alar rim collapse on mild to moderate inspiratory effort, middle vault narrowing, or narrow internal nasal valve on anterior rhinoscopy/endoscopy. The absence of significant concomitant mucosal disease, or any endo-nasal anatomic malformation, was confirmed by nasal endoscopy, hence excluding patients with rhinosinusitis, nasal polyposis or moderate/significant septal deviation, which would contribute to the breathing impairment.
Among the exclusion criteria was chronic airway disease of the lower respiratory tract such as asthma and/or COPD (chronic obstructive airway disease), which would interfere with a reliable PNIF result (8) . A thorough medical history was taken, focusing on nasal medications and previous nasal surgery.
Objective assessment of airflow
Nasal flow was evaluated using the portable inspiratory flow meter (Clement Clarke International, Essex, UK) while the patient was seated with an attached anesthetic mask. A soft facemask was used to ensure a tight seal and to avoid distortion of the nose or compression on the external nares. Patients were instructed to take a maximal forced inspiratory effort through the nose with the mouth closed. Three consecutive measurements with an inter-measurement variability of less than 10% were recorded, and the best result was noted, as in previous studies (9) . This value of PNIF was considered the baseline value.
Patient reported nasal obstruction
The selected patients were asked to rate overall their nasal obstruction using a VAS score from 0 to 100mm, where 0 indicates no obstruction and 100mm indicates total obstruction. A number was then obtained from 0 to 100 for severity of nasal obstruction at base line. During the follow up visit, patients gave a VAS score on general satisfaction on each device, and were asked questions regarding usage, tolerability, preference, intention to use in the future, or reasons for discontinuation.
Statistical analysis
Data were analyzed with GraphPad Prism 5 software (GraphPad Software, La Jolla, CA, USA). Differences between groups were analyzed by using the 2-tailed unpaired t test or Mann-Whitney Finally the patients were asked to choose 2 out of the 4 devices they tried in the clinic, for personal use. They were instructed to use one dilator for the first week and the other for the following week. After that period, they were free to use the device of their choice, until a phase of four weeks was complete. The patients were obliged to keep a diary during this time. They were handed a leaflet of printed entries for 30 days, along with the names of the devices. They had to complete the form, each and every time they were using a nasal dilator, and for every activity sepa- Figure 1A . PNIF values at baseline vs with dilators. Figure 1B ). VAS scores on nasal obstruction at baseline vs with dilators. Table 1 .
Improvement of PNIF with nasal dilators
Median baseline PNIF values were 105 (80-150) l/min, with the median PNIF achieved by each dilator demonstrated in Figure   1A . The median percentage of PNIF increase per dilator in comparison with base line values is shown in Table 2 .
Improvement of subjective nasal obstruction with nasal dilators VAS scores on nasal obstruction with the dilators in situ were significantly decreased compared with the baseline values ( Figure 1B ). 
Patients' preference of nasal dilators
Patient`s satisfaction and reasons for discontinuation
Regarding satisfaction during the follow-up visit, and after 4 weeks of usage, 67% of the patients are willing to keep using at least one of the chosen dilators and 33% prefer to discontinue (Figure 2 ).
The satisfaction rates for each device are shown in Figure 3 . The reasons for discontinuation were primarily local irritation, inappropriate fit, preference for a permanent solution like surgery, and no relief of symptoms ( Table 4 ). The reasons for discontinuation per dilator are shown in Figure 4 .
Discussion
The present study compares the ability of one external nasal dilator, and three endo-nasal dilators to produce improvements on subjective and objective parameters in 100 consecutive patients with NVC. The study was designed in order to discover the efficacy of mechanical stents and any beneficial advantage of one device over the others, when treating with non-surgical options, nasal obstruction in the context of valvular pathology.
Numerous studies have analyzed the benefits of various nasal dilators on healthy individuals (10) (11) (12) , healthy athletes (13, 14) , snorers (15) (16) (17) , patients with obstructive sleep apnoea (18, 19) , patients with sleep-disordered breathing (20) , pregnant women (21) , cancer patients (22) and more recently on children (23, 24) .
Roithmann et al. studied the effects of external nasal dilators
(END) on the cross sectional area of the nasal valve in patients with nasal obstruction following rhinoplasty (25) . Riechelmann et al. tested 10 healthy controls and 10 patients with alar collapse by using an internal nasal dilator (IND). They concluded that an IND effectively enlarged the region of the ENV, abolished alar collapse and improved nasal airflow (26) . Gruber et al. evaluated
and classified valvular nasal obstruction using external nasal strips (27) . Hellings & Trenité reported on 30 patients with ENV dysfunction that used an IND, and concluded that this represents a good alternative to surgery (28) .
Often these studies present limitations, such as restricted number of patients (10, 15) or absence of relevant objective data. Repeatedly, the reported improvement of nasal flow achieved by the dilators is demonstrated by either acoustic rhinometry (10, 13, 29) or rhinomanometry (12, 30, 31) . Although these tests were considered the most favored objective tests to measure nasal patency, studies regarding their validity are equivocal (32, 33) . To that effect the No relief of symptoms 20
Other (e.g. Difficulty with placement) 3 been discouraged owing to their poor correlation with subjective outcomes (1) .
In a systematic review and expert consensus statement that was achieved in 2010, was indicated that the use of alternative mechanical stents, such as external nasal dilator strips or internal nasal dilators, has a role in some patients with nasal valve compromise (1) . In the same document it is noted that, although patients who are poor surgical candidates because of underlying medical comorbidities or those who do not wish to undergo surgery may find the use of these mechanical stents helpful to treat the lateral nasal wall collapse, these devices are not always effective. Despite the fact that the use of nasal dilators has become more common in the recent years, there is indeed lack of clinical evidence in the literature, regarding their efficacy in targeted groups of patients with the diagnosis of NVC.
At present, patients with nasal valve dysfunction are being proposed to undergo either corrective valve surgery or a conservative approach using nasal dilators, without surgeons being able to give an estimate satisfaction rate of the latter.
For this study we utilised subjective and objective parameters.
The subjective parameters were the VAS scores achieved by the patients. The objective test used, was the PNIF. A European consensus group recently stated that PNIF measurements are the best-validated technique for the evaluation of nasal flow through the nose (34) . Additionally, evidence from the literature is emerging, that PNIF is the most robust tool to assess improvement in collapsibility, and aligns with improvements in subjective results, in patients with ENV deficiency that undergo rhinoplasty (35) .
As it is highlighted in the results, the increase in PNIF was It has been suggested in the literature that changes in the nasal geometry of the anterior part of the nose by an END affects the pattern of nasal airflow and transforms it into a laminar pattern (36) . Changing the nasal geometry with a nasal dilator is achieved by widening the nasal passage and by making structural components less prone to collapse. Internal stenting of the alae has also been shown to inhibit collapse at the lateral nasal wall and to increase PNIF in previous studies (37, 38) . Similarly to the effects of functional rhinoplasy, when making the structural components of the ENV more rigid, other components of the lateral nasal wall such as the INV, may be affected (35) . The effects of the nasal dilators cannot be isolated, and it is likely that affect components of both INV and ENV simultaneously.
The current study demonstrates that after 4 weeks of usage, 
Conclusion
This study puts to the test four different nasal dilators, in a 100 patients with NVC as the primary cause of nasal obstruction. Internal nasal dilators were associated with statistically significant improvement on PNIF values, but not the external nasal dilators.
However all dilators decreased the VAS scores for nasal obstruction on all patients.
Nasal anatomy and physiology is unique across individuals, and nasal valve dysfunction should always be treated with a tailored regimen specific to the individual deformities. As we move towards a better understanding of the dynamics of the nasal skeleton and the complex nature of rhinoplasty for repair of the weak lateral nasal wall, we should keep in mind that nonsurgical options are also available, and that can play a role in our diagnostic and therapeutic strategies.
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